- SITE CHAIR, OTOLARYNGOLOGY, MOUNT SINAI ROOSEVELT, MOUNT SINAI ST. LUKE'S
- PROFESSOR AND SYSTEM CHAIR Otolaryngology
- PROFESSOR Neurosurgery
- Esophageal Cancer
- Esophageal Stricture
- Facial Fracture
- Fine Needle Biopsy
- Laryngeal Cancer
- Lymph Node Biopsy
- Melanoma Removal
- Needle Biopsy: Thyroid
- Nose Fracture
- Open Reduction And Internal Fixation Surgery
- Robot-Assisted Surgery - Overview
- Skin Biopsy
- Skin Cancer
- Skin Graft
- Soft Tissue Sarcoma
- Squamous Cell Carcinoma
- Throat Cancer
- Thyroid Cancer
- Tongue Cancer
MD, Mount Sinai School of Medicine
Barnes Jewish Hospital
Fellowship, Head & Neck Surgery
Mount Sinai Hospital
Dr. Eric M. Genden is Chairman of the Department of Otolaryngology and Associate Professor of Otolaryngology-Head and Neck Surgery, and Immunobiology. As Chief of the Division of Head and Neck Oncology, Dr. Genden is board certified in head and neck surgery and fellowship trained in head and neck oncology and microvascular reconstruction. His practice is centered on thyroid, parathyroid surgery, head and neck cancer surgery, and airway reconstruction. Dr. Genden is nationally recognized as a leader in head and neck cancer surgery and head and neck microvascular reconstruction. He is the surgical director of the Multidisciplinary Program for Head and Neck Cancer. Dr. Genden is currently a member of the New York Head and Neck Society, American Head and Neck Society, American Board of Facial Plastic and Reconstructive Surgery, and the American Broncho-Esophagological Association.
To read more about Mount Sinai's Department of Ear, Nose and Throat, click here.
Dr. Genden discusses the link between smoking and head and neck cancers in The Daily News feature The Daily Check Up. View the PDF.
Broyles- Maloney Award, Honorable Mention
American Broncho-esophagology Association
Educator of the Year
Mount Sinai School of Medicine
Head and Neck Surgery's Honor Award
American Academy of Otolaryngology
Best Clinical Innovations Award
The Academy of Osseointegration, 18th Annual Meeting
Physician of the Year
The Mount Sinai Medical Center
Resident Research Program Presentation, First Place
New York Academy of Sciences
Excellence in Teaching
Genden EM, Ferlito A, Shaha AR, Talmi YP, Robbins KT, Rhys-Evans PH, Rinaldo A. Complications of neck dissection. Acta Otolaryngol 2003 Sep; 123(7): 795-801.
Genden EM, Ferlito A, Shaha AR, Rinaldo A. Management of cancer of the retromolar trigone. Oral Oncol 2003 Oct; 39(7): 633-7.
Genden EM, Okay D, Stepp MT, Rezzaee RP, Mojica JS, Buchbinder D, Urken ML. Comparison of functional and quality-of-life outcomes in patients with and without palatomaxillary reconstruction: a preliminary report. Arch Otolaryngol Head Neck Surg 2003 July; 129(7): 775-80.
Teng MS, Genden EM, Buchbinder D, Urken ML. Subcutaneous mandibulotomy: a new surgical access for large tumors of the parapharyngeal space. Laryngoscope 2003 Nov; 113(11): 1893-7.
Genden EM, Urken ML. Laryngotracheal Transplantation: Ethical Limitations. Mt Sinai J Med 2003 May; 70(3): 163-5.
Genden EM, Rinaldo A, Suarez C, Wei WI, Bradley PJ, Ferlito A. Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol 2004 Nov; 40(10): 979-84.
Robbins KT, Ferlito A, Suarez C, Brizel DM, Bradley PJ, Pellitteri PK, Clayman GL, Kowalski LP, Genden EM, Rinaldo A. Is there a role for selective neck dissection after chemoradiation for head and neck cancer? . J Am Coll Surg 2004 Dec; 199(6): 913-6.
Genden EM, Rinaldo A, Shaha AR, Bradley PJ, Rhys-Evans PH, Ferlito A. Pharyngocutaneous fistula following laryngectomy. Acta Otolaryngol 2004 Mar; 124(2): 117-20.
Morris L, Govindaraj S, Genden EM. Primary sphenoid sinus esthesioneuroblastoma. Am J Otolaryngol 2004 Sep-Oct; 25(5): 350-3.
Wallace D, Genden EM, Urken ML. Reconstruction of the hard palate with the radial forearm free flap: Outcomes and Quality of Life. Head Neck 2004 Sep; 26(9): 808-14.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Genden did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 10 Room 42
1468 Madison Avenue
New York, NY 10029
5 East 98th Street
New York, NY 10029
- Monday 1:00pm - 5:00pm
- Thursday 9:00am - 5:00pm
- First Health
- Oxford (Medicare)
- Oxford Freedom
- Railroad Medicare
- United Healthcare - Mount Sinai group only
- Personal Check